By Campbell McIlroy
Friday 15th February 2002 |
Text too small? |
Shares in the company dropped as much as 16% in morning trading, bottoming out at $11.75 before recovering to about $12 at lunch time. Brokers said the markets had been punishing companies which failed to deliver to the level expected. "FHP did that today and was punished," one said.
Operating revenue for the three months ended December 31 was up a disappointing 1% to $55.8 million.
Analysts said increased demand in the company's core products had led to lower prices and started to squeeze the company's margins.
New products were also yet to bear fruit with some sectors already showing signs of increased competition. The company was also struck by bad luck with a mild northern winter resulting in a mild flu season and fewer humidifier sales.
One broker said it was surprising FHP hadn't given the market any indication of the sales levels it had been experiencing.
Across the three product groups FHP revealed operating revenues increased in the respiratory humidification group by 4% to $29 million, CPAP sleep apnea group was up 10% to $19.8 million and the patient warming and neonatal care group was up 9% to $3.6 million.
No comments yet
ikeGPS Chief Financial Officer Transition
TWL - TradeWindow announces strategic partnership with FTA
BLT - Patent issue settled and new 5 year agreement with BSP
July 2nd Morning Report
July 1st Morning Report
June 27th Morning Report
SDL - FY2026 Earnings Guidance
PaySauce Director resigns for US-based role with NZTE
General Capital Releases 2025 Annual Report
June 26th Morning Report